| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |